|
|
|
11-50 employees
View all
|
|
pharmaceuticals
|
|
300B Corporate Court,South Plainfield,New Jersey,US
|
|
Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and significant mortality. Comorbidities are a common consequence of sickle cell disease, chemotherapy, atherosclerosis, diabetes and many other diseases. - The company's lead product, SANGUINATEā¢, is focused on treating the comorbidities of sickle cell disease and hemorrhagic stroke - Prolong has a long-acting 3rd generation biologic in clinical development for the treatment of anemia, a comorbidity common with chronic kidney disease and cancer chemotherapy - Other products are also in development for comorbidities that result from diseases such as cardiovascular disorders and cancer ___________
|
Prolong Pharmaceuticals Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
60%
|
The widely used Prolong Pharmaceuticals email format is {f}{last} (e.g. [email protected]) with 60% adoption across the company.
To contact Prolong Pharmaceuticals customer service number in your country click here to find.
Abe Abuchowski is the CEO of Prolong Pharmaceuticals. To contact Abe Abuchowski email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.